DRMAW

This security represents warrants of Dermata Therapeutics, Inc., a clinical-stage biotechnology company. Each warrant typically entitles the holder to purchase one share of common stock at a predetermined exercise price. These warrants were likely issued in connection with a financing transaction or business combination. The warrants provide leveraged exposure to Dermata's clinical development progress and potential commercialization success. Warrant value is influenced by the underlying stock price, time to expiration, volatility, and the exercise price relative to the current stock price.